Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Gene therapy for neurological disorders: progress and prospects.

Deverman BE, Ravina BM, Bankiewicz KS, Paul SM, Sah DWY.

Nat Rev Drug Discov. 2018 Oct;17(10):767. doi: 10.1038/nrd.2018.158. Epub 2018 Sep 12.

PMID:
30206384
2.

Gene therapy for neurological disorders: progress and prospects.

Deverman BE, Ravina BM, Bankiewicz KS, Paul SM, Sah DWY.

Nat Rev Drug Discov. 2018 Sep;17(9):641-659. doi: 10.1038/nrd.2018.110. Epub 2018 Aug 10. Review. Erratum in: Nat Rev Drug Discov. 2018 Oct;17(10):767.

PMID:
30093643
3.

Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.

Siepel FJ, Brønnick KS, Booij J, Ravina BM, Lebedev AV, Pereira JB, Grüner R, Aarsland D.

Mov Disord. 2014 Dec;29(14):1802-8. doi: 10.1002/mds.26051. Epub 2014 Oct 4.

PMID:
25284687
4.

Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations.

Gewandter JS, Dworkin RH, Turk DC, McDermott MP, Baron R, Gastonguay MR, Gilron I, Katz NP, Mehta C, Raja SN, Senn S, Taylor C, Cowan P, Desjardins P, Dimitrova R, Dionne R, Farrar JT, Hewitt DJ, Iyengar S, Jay GW, Kalso E, Kerns RD, Leff R, Leong M, Petersen KL, Ravina BM, Rauschkolb C, Rice AS, Rowbotham MC, Sampaio C, Sindrup SH, Stauffer JW, Steigerwald I, Stewart J, Tobias J, Treede RD, Wallace M, White RE.

Pain. 2014 Sep;155(9):1683-95. doi: 10.1016/j.pain.2014.05.025. Epub 2014 May 24. Review.

5.

Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.

Potashkin JA, Santiago JA, Ravina BM, Watts A, Leontovich AA.

PLoS One. 2012;7(8):e43595. doi: 10.1371/journal.pone.0043595. Epub 2012 Aug 27.

6.

Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study.

Ding H, Sarokhan AK, Roderick SS, Bakshi R, Maher NE, Ashourian P, Kan CG, Chang S, Santarlasci A, Swords KE, Ravina BM, Hayes MT, Sohur US, Wills AM, Flaherty AW, Unni VK, Hung AY, Selkoe DJ, Schwarzschild MA, Schlossmacher MG, Sudarsky LR, Growdon JH, Ivinson AJ, Hyman BT, Scherzer CR.

Mov Disord. 2011 Oct;26(12):2283-6. doi: 10.1002/mds.23934. Epub 2011 Sep 23.

7.

Finances of the publishers of the most highly cited US medical journals.

Dorsey ER, George BP, Dayoub EJ, Ravina BM.

J Med Libr Assoc. 2011 Jul;99(3):255-8. doi: 10.3163/1536-5050.99.3.013. No abstract available.

8.

Predictors of cognitive outcomes in early Parkinson disease patients: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.

Schneider JS, Elm JJ, Parashos SA, Ravina BM, Galpern WR; NET-PD Investigators.

Parkinsonism Relat Disord. 2010 Sep;16(8):507-12. doi: 10.1016/j.parkreldis.2010.06.001. Epub 2010 Jul 2.

9.

Proof of concept studies for tissue-protective agents in multiple sclerosis.

Mehta LR, Schwid SR, Arnold DL, Cutter GR, Aradhye S, Balcer LJ, Calabresi PA, Cohen JA, Cole PE, Glanzman R, Goelz S, Inglese M, Kapoor R, Kappos L, Kreitman R, Lublin FD, Mann A, Marrie RA, O'Looney P, Polman CH, Ravina BM, Reingold SC, Richert JR, Sandrock AW, Waubant E.

Mult Scler. 2009 May;15(5):542-6. doi: 10.1177/1352458508101939. Review.

PMID:
19389749
10.

Neuroprotection trials in Parkinson's disease: systematic review.

Hart RG, Pearce LA, Ravina BM, Yaltho TC, Marler JR.

Mov Disord. 2009 Apr 15;24(5):647-54. doi: 10.1002/mds.22432. Review.

PMID:
19117366
11.

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers.

Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VM, Leverenz JB, Masliah E, McKeith IG, Nussbaum RL, Olanow CW, Ravina BM, Singleton AB, Tanner CM, Trojanowski JQ, Wszolek ZK; DLB/PDD Working Group.

Neurology. 2007 Mar 13;68(11):812-9. Review.

PMID:
17353469
12.

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM.

Neurology. 2007 Jan 30;68(5):384-6. Epub 2006 Nov 2.

PMID:
17082464
13.

Biomarkers in Parkinson's disease.

Dorsey ER, Holloway RG, Ravina BM.

Expert Rev Neurother. 2006 Jun;6(6):823-31. Review.

PMID:
16784406
14.

Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment.

Ravina BM, Fagan SC, Hart RG, Hovinga CA, Murphy DD, Dawson TM, Marler JR.

Neurology. 2003 Apr 22;60(8):1234-40. Review.

PMID:
12707423

Supplemental Content

Loading ...
Support Center